Company
Investment-firm
Last deal
Amount
Stage
Date
all rounds
Financing round
General
About Company
Industry
Sector :
Subsector :
Also Known As
founded date
founders
Number of employees
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Inception Fund
Inception Fund is a Seattle-based venture capital firm specializing in cancer biotechnology and late-stage technology companies.
Sector
Subsector
Keywords
Location
count Of Investments
Sangel Capital
Sangel Capital is a professional biomedical venture capital institution operating globally since 2010.
Sector
Subsector
Location
count Of Investments
IBT Management Corporation
IBT Management Corp invests in early- to mid-stage high tech companies to help them grow and gain a competitive advantage.
Sector
Subsector
Location
count Of Investments
count Of Exists
Kendall Capital Partners
Kendall Capital Partners is a venture capital firm focusing on early-stage investments in biotechnology and medical care.
Sector
Subsector
Keywords
Location
count Of Investments
Financials
Funding Rounds1
Number of Funding Rounds
Their latest funding was raised on 17.10.2023. Their latest investor Kohlberg Kravis Roberts. Their latest round Private Equity
Kohlberg Kravis Roberts
Kohlberg Kravis Roberts is a global investment firm that manages multiple alternative asset classes.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Investments60
Noetik
Noetik is an AI-native biotech company that uses advanced machine learning to develop cancer immunotherapies.
Sector
Subsector
Keywords
total rounds
total raised
Imperative Care
Imperative Care develops innovative medical technology for stroke intervention.
Sector
Subsector
Keywords
Location
total rounds
total raised
InSightec
InSightec is the global leader in MR guided focused ultrasound technology for image guided acoustic surgery.
Sector
Subsector
Location
total rounds
total raised
Co-Investors
Investors1
Number of lead investors
Number of investors
Kohlberg Kravis Roberts
Kohlberg Kravis Roberts is a global investment firm that manages multiple alternative asset classes.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Ali Satvat
Ali J. Satvat (Menlo Park) joined KKR in 2012 and is a member of the Health Care industry team within KKR’s Private Equity platform. He currently serves on the board of directors of Arbor Pharmaceuticals, Coherus BioSciences and PRA Health Sciences. Prior to joining KKR, Ali Satvat was a principal with Apax Partners, where he invested in health care, served as a director of Chiron Holdings (Kinetic Concepts / LifeCell) and TZ Holdings (The TriZetto Group) and was actively involved with many of the firm’s successful growth investments. Previously, Ali Satvat held various positions with Johnson & Johnson Development Corporation, Audax Group and The Blackstone Group, where he was involved in a broad range of transactions. Ali Satvat holds an A.B., magna cum laude, in History and Science from Harvard College and an M.B.A. in Health Care Management and Entrepreneurial Management from the Wharton School of the University of Pennsylvania. Ali Satvat is a member of the board of directors of the Healthcare Private Equity Association.
current job
Henry Kravis
Henry R. Kravis is the Co-Founder and Co-Executive Chairman at Kohlberg Kravis Roberts. He attended the Claremont McKenna College.
current job
organization founded
Exits1
Personal Genome Diagnostics
Personal Genome Diagnostics develops advanced tools and technologies for patient-specific analysis of the cancer genome.
Sector
Subsector
Keywords
Location
total rounds
total raised
People
Founders2
Jacob Vogelstein
Jacob Vogelstein is a Co-Founder and Managing Partner at Catalio Capital Management, LP. He attended The Johns Hopkins University School of Medicine.
current job
organization founded
Jacob Vogelstein
George Petrocheilos
General Partner at Camden Partners, a Baltimore-based, private equity firm, that spun out of T. Rowe Price in 1995. Co-founded Camden Partners Nexus, our early-stage strategy, focusing in biomedical & digital technologies with strong intellectual property. Investing in biomedical tech companies - drugs, devices and diagnostics. On a variety of non-profit boards, including the Baltimore School for the Arts, Johns Hopkins Center for Financial Economics, Johns Hopkins Sheridan Libraries, and Living Classrooms Foundation. Received a BA in Economics from the Johns Hopkins University.
current job
organization founded
George Petrocheilos
Employee Profiles4
Activity
Recent News27
The graph reveals the ratio (%) of positive news articles in a chosen time range